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Differentiation of neuronal cells is crucial 
for the development and function of the nervous 
system. This process involves high rates of 
membrane expansion, during which the synthesis 
of membrane lipids must be tightly regulated. In 
this work, using a variety of molecular and 
biochemical assays and approaches, including 
immunofluorescence microscopy and FRET 
analyses, we demonstrate that the proto-oncogene 
c-Fos (c-Fos) activates cytoplasmic lipid 
synthesis in the central nervous system and 
thereby supports neuronal differentiation. 
Specifically, in hippocampal primary cultures, 
blocking c-Fos expression or its activity impairs 
neuronal differentiation. When examining its sub-
cellular localization, we found that c-Fos co-
localizes with endoplasmic reticulum markers and 
strongly interacts with lipid-synthesizing 
enzymes, whose activities were markedly 
increased in vitro in the presence of recombinant 
c-Fos. Of note, the expression of c-Fos dominant-
negative variants capable of blocking its lipid 
synthesis–activating activity impaired neuronal 
differentiation. Moreover, using an in utero 
electroporation model, we observed that neurons 
with blocked c-Fos expression or lacking its AP-
1–independent activity fail to initiate cortical 
development. These results highlight the 
importance of c-Fos–mediated activation of lipid 
synthesis for proper nervous system development.  
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Neuronal differentiation, an intricate 
cellular process, comprises a series of complex 
and coordinated events such as cell proliferation, 
migration and differentiation (1-5). To reach its 
final structure and establish functional neuronal 
circuits, a neuron must promote neuritogenesis, 
neurite elongation, polarization, arborization and 
synaptogenesis (6-8). The proper function of the 
nervous system heavily relies on the number of 
multiple and targeted synaptic contacts 
established by each neuron. Sprouting of axon 
branches along the axon shaft allows multiple 
innervation targets (9). The overall process of 
neuronal differentiation determines patterns of 
connectivity of neuronal circuits whereas the 
disruption of these patterns may cause severe 
pathologies or developmental disorders (10,11).  
Outgrowth events involve cellular 
volume and surface area increase, thus demanding 
membrane material that must be supplied 
according to the temporal and spatial 
requirements of the cells in their different 
developmental stages (5,6,12-14). In fact, 
membrane expansion can reach an increment of 
up to 20% according to the different steps of 
neuronal differentiation (13).  
Considering their architecture and size, it 
is reasonable to hypothesize that neurons will 
need temporal and domain-specific mechanisms 
to regulate the synthesis of the components 
required according to their local demands. In line 
with this hypothesis, Tsukita and co-workers 
provided evidence of the three-dimensional 
structure of the endoplasmic reticulum (ER) in 
axonal processes (15). Several reports later 
convincingly demonstrated a synthetic machinery 
present in axons, with capacity to regulate the 
levels of proteins, lipids and other 
macromolecules (16,17). Consequently, the 
mechanisms by which neurons supply 
components for membrane biogenesis such as 
lipids in growing axons have been the subject of 
several studies. Using compartmented culture 
systems, compelling evidence emerged 
demonstrating that axons carry out active lipid 
synthesis (18-20).     
The expression of Fos, an oncogene of the 
Immediate Early Genes (IEGs) family, is rapidly 
and transiently induced in different cell types by 
diverse stimuli (i.e. growth factors, 
neurotransmitters) (21-23). The proteins of the 
Fos family (c-Fos, Fos-B, ΔFos-B, Fra-1, Fra-2) 
heterodimerize mainly with those of the Jun 
family, comprising the well-known AP-1 
transcription factors (24). Our laboratory 
described c-Fos as a moonlighting protein capable 
of achieving an additional, non-AP-1 function: it 
associates to the ER membranes and activates 
lipid synthesis through an interaction with 
specific lipid synthesizing enzymes (25-31). 
Using PC12 cells, we distinguished between the 
two known functions of c-Fos, that is, its AP-1 
activity and its capacity to activate lipid synthesis. 
Initially, when cells are stimulated with nerve 
growth factor (NGF) to differentiate into a 
sympathetic neuron phenotype, c-Fos is required 
in the nucleus to trigger the genomic program of 
differentiation. However, once the cells have been 
primed to differentiate, c-Fos is only required at 
the cytoplasm, associated to the ER, activating 
phospholipid synthesis, for cells to continue 
differentiating (32).  
Herein, using hippocampal neurons we 
evidenced that c-Fos is capable of exerting its 
lipid synthesis activator capacity in the nervous 
system and that this AP-1-independent activity is 
crucial for normal neuronal differentiation. 
Furthermore, by in utero electroporation we 
demonstrate that this role is involved in cortical 
development. In this direction, c-Fos could be an 
active player in different events required for 
neuronal plasticity, such as those involved in 
learning and memory formation.  
 
Results 
c-Fos expression during neuronal 
differentiation 
The presence of c-Fos in the brain, and 
more specifically in the hippocampus, has been 
demonstrated almost 30 years ago by Dragunow 
and co-workers (33,34). We initially evaluated c-
Fos expression over time in primary cultures of rat 
hippocampal neurons. At all times examined, c-
Fos is expressed at similar levels even after 96 
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hours in culture, as determined by 
immunocytochemistry and Western Blot (Figure 
1). It is important to highlight that c-Fos 
expression is observed not only in the nucleus but 
also extending to the entire cytoplasm of the 
neurons.   
We then evaluated if c-Fos participates in 
the differentiation of rat hippocampal neurons. 
The method applied to determine the 
differentiation stage of the cultured cells was the 
one described by Dotti and co-workers (7). 
Briefly, cells in stage 1 of differentiation, shortly 
after they attach to the substrate, show motile 
lamellipodia developed around the periphery of 
the cell. At stage 2, these lamellipodia begin to 
transform into distinct minor processes that 
extend to a length of up to 10-15 µm. At stage 3, 
one of these minor processes begins to grow 5 to 
10 times faster than the rest of them, indicating 
that the axon of the cell has been formed and the 
cell has polarized. At stage 4, a significant 
development of dendrites initiates and finally, at 
differentiation stage 5, the axonal and dendritic 
arbors suffer a maturation process.   
To evaluate the effect of blocking c-Fos 
activity during this complex process, primary 
cultures of rat hippocampal neurons were 
profected at 2 hours of culture with anti c-Fos 
antibodies or with a non-related antibody as a 
control using the BioPorter system.  Cells were 
examined 48 hours later by 
immunocytochemistry but only using secondary 
antibodies in the case of the anti-c-Fos-profected 
cells. As can be seen in the graphs of Figure 2A, 
blocking c-Fos activity impairs axon formation. 
We quantified different morphological features of 
the neurons observing that there were no changes 
in soma size or in the mean number of neurites per 
cell when comparing cells lacking c-Fos activity 
and the control ones. It should be noticed that we 
were not able to observe the development of 
axonal-like processes even after 48 hours of 
culture when c-Fos activity was impaired, a 
phenomenon not observed in the control cells 
(Figure 2A).   
These results were confirmed by blocking 
c-Fos expression. When neurons are infected two 
hours after seeding with lentiviral vectors 
designed to express a specific shRNA against c-
Fos, impaired differentiation is clearly observed 
(Figure 2B). When neurons are classified into the 
differentiation stages according to their 
morphology, more than 85% of the c-Fos-
knocked-down neurons remained at stages 1 and 
2 of differentiation as compared to the almost 
50% of neurons in stages 3 and 4 of the control 
cultures (Figure 2C). 
 
c-Fos co-localizes with ER markers in neuronal 
processes 
Previous studies from our laboratory have 
shown that upon a subcellular fractionation of 
PC12 cell homogenates, c-Fos and the ER 
membranes are predominantly collected in the 
same fraction (35). This led us to examine if the 
c-Fos/ER co-localization observed previously can 
be evidenced in neurons of the central nervous 
system as well. To test this, we performed 
immunocytochemistry assays on primary rat 
hippocampal neurons after 48 hours of culture 
and, as expected, a strong co-localization of c-Fos 
with the ER marker Calnexin was detected 
(Figure 3). Surprisingly, c-Fos and the ER were 
found not only in the perinuclear region of the 
soma; defined co-localization dots at punctuate 
structures confined to axonal branching points 
were also very frequently observed.  
 
c-Fos activation of lipid synthesizing enzymes in 
neurons 
Previous results from our group have 
demonstrated that c-Fos physically interacts with 
and activates particular enzymes of the lipid 
synthesis pathways. Such is the case for CDP-
diacylglycerol Synthase (CDS), 
Phosphatidylinositol 4 Kinase II-alpha (PI4KIIα) 
and Lipin1 (29,31). Taking this into 
consideration, it was hypothesized that c-Fos 
could be involved in neuronal differentiation by a 
lipid-activating mechanism that requires its 
physical interaction with specific enzymes. To 
this end, we examined the possible interaction of 
c-Fos with CDS, the enzyme that catalyzes the 
conversion of phosphatidic acid (PtdOH) into 
CDP-diacylglycerol (CDP-DAG), the first step of 
phosphatidylinositol-phosphate (PtdInsP) 
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synthesis in the ER. To infer protein-protein 
interactions, Förster Resonance Energy 
Transfer (FRET) experiments were performed 
(36). For this, rat primary hippocampal neurons 
were co-transfected to express c-Fos-
mTurquoise2 and CDS-SYFP2 and examined by 
confocal microscopy. As shown in Figure 4A and 
B, a positive FRET phenomenon is observed 
between both proteins, indicating that there is 
indeed a physical interaction between them.  
To study if this physical interaction leads 
to enzyme activation, CDS activity was assayed 
using cell homogenates obtained from rat 
hippocampal neurons as the enzyme source and 
3H-CTP and dioleoyl-PtdOH as substrates, with or 
without the addition of recombinant c-Fos to the 
incubates (29,37,38). At the times assayed, about 
40% more CDP-DAG was synthetized in the +c-
Fos incubates as compared to the control (Figure 
4C). This confirms that the lipid synthesis 
activation mediated by c-Fos observed previously 
also occurs in hippocampal neurons in culture. 
The association of c-Fos to 
CTP:phosphocholine cytidylyltransferase (CCT), 
the rate limiting enzyme in phosphatidylcholine 
(PtdCho) synthesis (Supplementary Figure 1) 
suggests that c-Fos could be also mediating the 
activation of other phospholipid pathways.  
 
Neuronal differentiation is impaired in cells 
lacking cytoplasmic c-Fos 
The results shown so far support the need 
of c-Fos to normally complete the differentiation 
events. However, they do not allow us to discern 
if the effect is due to the AP-1or the lipid synthesis 
activator function of c-Fos. In order to activate 
lipid synthesis, c-Fos associates through its N-
terminal domain (NA domain, amino acids 1-138 
of full length c-Fos) to the enzymes it activates 
(29,31,32). However, this portion of the protein is 
not sufficient to produce lipid synthesis activation 
because of the absence of the basic domain (BD, 
amino acids 139-159), a domain required for 
enzyme activation to occur. As the NA domain is 
not involved in c-Fos AP-1 functions, it seems 
reasonable to propose its use as a negative 
dominant of its lipid synthesis activator function. 
That is, the NA should interfere only with the lipid 
synthesizing function of c-Fos and not with its 
AP-1, transcriptional one. Furthermore, we have 
previously shown that recombinant NA is not able 
to activate total phospholipid synthesis and 
inhibits CDS activity (30,38). 
Taking this into consideration, we 
examined if the impairment in neuronal 
differentiation could be linked to the lack of c-
Fos-dependent lipid synthesis activity. 
Hippocampal neuronal cells were transfected with 
a construct that contains the NA domain, that does 
not activate lipid synthesis, or with the construct 
NB that contains amino acids 1 to 159 (NB 
domain), which is capable of activating lipid 
synthesis at comparable levels to those of full 
length c-Fos, both fused with YFP. The empty 
vector was used as a control. Then the 
differentiation stages of the transfected cells at 
different fixation times were analyzed. It can be 
seen in Figure 5A and its quantification in 5B 
(cells fixed at 48h) that the expression of the NA 
domain impairs neuronal differentiation as 
evidenced after a morphological analysis and 
stage quantification of the NA transfected cells 
relative to the NB or non-transfected ones. Even 
more, it is clear that the impairment in 
differentiation promoted by the NA domain is 
comparable to that observed when c-Fos 
expression is blocked (Figure 2B and C).  
In order to test if this effect was due to the 
lipid synthesis activator capacity of c-Fos, we 
performed biochemical assays to assess total 
phospholipid labeling in homogenates obtained 
from hippocampal neurons primary cultures. 
Previous reports have shown that the γ-phosphate 
group of labeled [32P]-ATP can be incorporated 
into different lipids of cell lysates assayed in vitro, 
mainly phosphatidylinositol and its derivatives 
and phosphatidic acid (39-44) and that 
recombinant c-Fos promotes an increase in their 
synthesis (45). When assaying this in neurons, it 
is clear that the addition of recombinant c-Fos to 
the assay promotes a significant increase in total 
phospholipid labeling, while recombinant NA 
does not (Figure 5C). However, if both c-Fos and 
NA are added together, the activating effect of c-
Fos is abolished. These results are compatible 
with a competition between c-Fos and NA for 
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binding of c-Fos to the enzymes as shown 
previously in other systems (38). This is also 
compatible with the notion that differentiation is 
impaired as a consequence of the lack of the lipid 
synthesis activator capacity of c-Fos.  
 
 
c-Fos is essential for cortical development 
We next studied if c-Fos participates in 
cortical development in vivo by using in utero 
electroporation. Briefly, the vertebrate cortex is 
organized into layers of neurons that share 
functions, morphology and birthdates (46). 
During development, radial glia progenitors in the 
ventricular zone (VZ) divide asymmetrically to 
originate cortical pyramidal projecting neurons. 
Then they suffer a radial migration process 
towards the marginal zone and through the 
subventricular zone (SVZ) and lower 
intermediate zone (IZ). In the IZ, neurons acquire 
a transient multipolar morphology where they 
extend and retract multiple dynamic projections 
and move in apparently random directions (47-
49). As cells approach the middle of the IZ, the 
genesis of the axon starts and when they reach the 
upper region of the IZ, they change their 
morphology from multipolar to bipolar and carry 
on radial migration (46,50,51).  
Using the electroporation model, it can be 
visualized if the manipulated neurons, that are 
destined to migrate to the upper layers of the brain 
cortex, suffer an impairment in this process or in 
the establishment of neuronal polarity. Cortical 
progenitors at embryonic day 15 (E15) were 
electroporated with a specific shRNA targeting c-
Fos and an analysis of the location and 
morphology of the progeny was performed at E19 
after in vivo differentiation. Visualization of the 
electroporated cells was achieved by co-
electroporating the shRNAs with a plasmid 
encoding the DsRed fluorescent protein. 
We first analyzed differentiation of cells 
electroporated with a non-relevant shRNA 
(shControl) plus DsRed at E19. About 10% of the 
neurons were located in the ventricular zone/sub-
ventricular zone (VZ/SVZ), 30% of cells were 
found migrating through the IZ and the majority 
(60%) had reached the top of the cortical plate 
(Figure 6A, left; quantification in 6B). Cells with 
knocked-down expression of c-Fos clearly 
showed an altered distribution and abnormal 
migration: around 80% of the cells remained 
arrested at the VZ/SVZ compared to the 10% in 
this localization in control experiments and 
practically no electroporated cells were observed 
in the upper CP (Figure 6A, right; quantification 
in 6B).  
Electroporation assays were then 
performed with the deletion mutants of c-Fos to 
evaluate if its lipid synthesis activator function is 
responsible for the abnormal phenotype observed 
when c-Fos expression is blocked. Electroporated 
cells of control experiments using the empty 
vector show a similar localization to that shown in 
the controls of Figure 6A (Figure 6C, left; 
quantification in 6D). By contrast, cells 
transfected with c-Fos NA domain that acts as a 
negative dominant of its lipid synthesis activator 
function, remained arrested at the VZ/SVZ and IZ 
(Figure 6C, right; quantification in 6D). These 
results support the notion that the AP-1-
independent function of c-Fos is in fact involved 
in cortical development.   
 
Discussion 
Although for a long time it was assumed 
that biosynthesis of most macromolecules in 
neurons was confined to the cell body (52,53), an 
increasing body of molecular evidence has 
supported the presence of functional ER resident 
components in axons (15-17,54-62). Together 
with the understanding of the complex structural 
features of the axonal ER, different studies 
provided emerging evidence of active, axon-
localized lipid synthesis (18,19,63-66). In fact, in 
the case of phosphatidylcholine synthesis, almost 
50% has been found to be locally synthesized in 
distal axons and it is required for axonal growth 
(20). Although this highlights the importance of 
the axonal ER in lipid homeostasis and in the 
maintenance of the complex structure of neurons, 
there have been no significant advances in the last 
years regarding the regulation of lipid metabolism 
in neurons.  
Taking into consideration that the plasma 
membrane surface area of a developing neuron 
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increases up to 20% per day (13) and that the 
compositional differences along the membrane 
due to the functional differences of axons and 
dendrites must necessarily be maintained, the 
molecular mechanisms regulating localized lipid 
synthesis must be carefully orchestrated. Since 
most of the local metabolic demands for axonal 
development, plasticity or regeneration must be 
rapidly supplied, it seems reasonable to propose 
that, at least in part, the mechanisms involved in 
lipid synthesis regulation could be independent of 
the cells’ nuclear activity. In the present work we 
provide evidence that confirms the existence of 
the AP-1-independent function of c-Fos as a lipid 
synthesis activator in the nervous system, 
particularly in rat hippocampal neurons in culture 
and in the developing brain cortex during 
embryonic stages.  
The fact that c-Fos is expressed during 
neuronal differentiation but is not in the adult 
brain in non-pathological conditions (67) implies 
that its expression is related to developmental 
events. c-Fos was described as a marker of 
neuronal activity, specially tied to learning and 
memory processes (68). In the experiments 
presented herein where c-Fos expression or its 
activity are blocked, neurons do not develop an 
axon and remain at early stages of differentiation 
without a distinguishable axon even after 48 hours 
of culture. Until now, the effects of c-Fos on 
neuronal plasticity have been always linked to 
gene expression through its nuclear function, but 
given the evidence presented herein, it is possible 
that they are associated to processes that involve 
changes in lipid homeostasis. This can be 
particularly visualized in the experiments carried 
out with negative dominants of the lipid synthesis 
activator function of c-Fos, where the same results 
of impairment on differentiation in culture are 
observed in spite that AP-1 activity should not be 
affected.  
This hypothesis can be extended to 
cortical development: when performing in utero 
experiments, the cells with no c-Fos expression 
remain at the ventricular and sub-ventricular 
zones instead of migrating to the superior layers 
of the cortex, an observation that implies a strong 
failure in normal cortical development. These 
results deepen our previous findings in the 
cerebral cortex of fos (-/-) mice, that show a strong 
reduction in the cortex thickness and a marked 
tendency of cells towards an undifferentiated 
phenotype (69). Since the in utero model does not 
have compensatory effects relying on other 
proteins that might fulfill the function of c-Fos, 
the phenotype observed in our experiments 
confirm the importance of this protein in cortex 
development. Even more, the same in utero 
experiments with negative dominants of its AP-1-
independent function show that this effect is 
directly related to its lipid synthesis activator role. 
However, the changes in the localization of the 
NA transfected cells are not as extreme as those 
observed in the c-Fos knocked-down cells. Two 
different interpretations arise from the 
intermediate phenotype observed in this case: 
both functions, AP-1 and lipid synthesis 
activation are actively involved in cortical 
development, or the expression level of the NA 
domain is not enough to displace all the 
endogenous c-Fos molecules. It remains to be 
determined if the observed phenotype is a 
consequence of failures in polarization or 
migration of the cells. 
c-Fos has been implicated in numerous 
physiological processes in the nervous system. It 
was the first transcription factor whose induction 
was proven to be dependent on the activity of the 
neuron (70,71), an evidence that rapidly 
transformed c-Fos in a marker of neuronal 
activity. In fact, it has been consistently 
demonstrated that its expression rises in the 
central nervous system after learning or memory 
trainings (68), although this changes are observed 
only during the first sessions of the protocols, 
indicating that this is probably an adaptive 
response. Given the results presented in this work, 
it seems reasonable to hypothesize that c-Fos lipid 
activator function could be involved in processes 
related to neuronal plasticity and learning 
processes by providing new membrane lipids for 
the establishment of new circuits that are no 
longer required once they are formed.  
In light of all the above mentioned results, 
the role of AP-1-independent c-Fos results of vital 
importance for neuronal development. Its lipid 
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synthesis activator capacity might contribute to 
the high membrane expansion rates necessary for 
the extension of the different neuronal processes 
that favor polarization and the correct 
establishment of synaptic connections for normal 




Cell cultures, profection and transfection. 
Dissociated hippocampal pyramidal neurons were 
prepared from fetal rat brain and cultured as 
described (72). Briefly, pregnant Rattus 
Norvegicus Wistar rats at 18 days post-
fertilization were euthanized and prenatal pups 
were excised from the uterus with sterile 
dissecting scissors. Pups were then decapitated 
with sterile scissors in a laminar flow hood and 
the removed heads were placed in plates with 
sterile Hank’s Balance Salt Solution (HBSS, 
Sigma Aldrich, St. Louis, Missouri, United 
States) at 4°C under a dissecting microscope. 
After hippocampus isolation and dissociation 
with Trypsin 0.25% (Thermo Fisher Scientific, 
Waltham, Massachusetts, United States), the 
tissue was dissociated with Pasteur pipettes. The 
cells obtained were plated onto acid washed, poly-
lysine-coated glass coverslips or poly-lysine-
coated plates and maintained in Dulbecco’s 
Modified Eagle Medium (DMEM, Thermo Fisher 
Scientific, Waltham, Massachusetts, United 
States) supplemented with 10% (v/v) Horse 
Serum (Thermo Fisher Scientific, Waltham, 
Massachusetts, United States) for 2 hours after 
which the culture media was replaced with serum-
free Neurobasal medium supplemented with N2 
and B27 supplements (Thermo Fisher Scientific, 
Waltham, Massachusetts, United States). Cultures 
were maintained in a humidified 37°C incubator 
with 5% CO2 during the indicated times.  
Profections were performed using 
BioPORTER® Protein Delivery Reagent 
(Genlantis, San Diego, California, United States) 
and transfections using Lipofectamine 2000 
(Thermo Fisher Scientific, Waltham, 
Massachusetts, United States) according to the 
manufacturer´s protocol.  
Production of shRNA containing lentiviral 
particles. Upon desired confluence, embryonic 
kidney epithelial HEK 293T cells (ATCC, 
Manassas, Virginia, United States) were co-
transfected with MISSION® c-Fos custom 
shRNA plasmids (clones ID TRCN0000042680 
and TRCN0000042678) cloned in pLKO.1-
CMV-tGFP (Sigma Aldrich, St. Louis, Missouri, 
United States) or with the control scrambled 
shRNA sequence and with compatible packaging 
plasmids using Lipofectamine 2000 (Thermo 
Fisher Scientific, Waltham, Massachusetts, 
United States). Lentiviral titer was determined 
according to the manufacturer’s protocol 
(MISSION®, Sigma Aldrich, St. Louis, Missouri, 
United States). 
Preparation of recombinant c-Fos and NA. His-
tagged c-Fos and NA were expressed and 
recovered from pDS56-HisFos-transformed 
BL21 cells as described previously (30,38,73).  
Co-immunoprecipitation assays, electrophoresis 
and Western Blot (WB). For co-
immunoprecipitation (co-IP) assays, 500 μg of 
total protein from cells treated as indicated were 
immunoprecipitated for 4 hours at 4°C with 
Protein G–Sepharose (GE Healthcare 
Biosciences, Chicago, Illinois, United States) 
with the desired antibody, washed and 
immunodetection performed as described below. 
Cell lysates (50 μg) or IPs were fractionated 
through SDS-containing polyacrylamide gels 
(12%) and electrotransferred to a nitrocellulose 
membrane at 300 mA during 1h. 
Immunodetection was carried out by blocking of 
membranes with 10 mM PBS containing 5% 
(w/v) non-fat dried milk for 1 hour at RT, 
followed by incubation with the desired antibody 
overnight at 4°C in PBS-0.1% (v/v) Tween-20 
(Sigma Aldrich, St. Louis, Missouri, United 
States). Membranes were washed three times (10 
min) with PBS-0.1% (v/v) Tween-20 and 
incubated for 1 hour at RT with secondary 
antibodies. Membranes were washed and 
detection performed using an ODYSSEY Infrared 
Imaging System (LI-COR, Lincoln, Nebraska, 
United States).   
In vitro phospholipid labelling. In vitro 
phospholipid labelling capacity of neurons was 
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assayed as described previously (32,74). Briefly, 
reactions were incubated for 60 minutes at 37°C 
in a final volume of 50 μL containing 50 μg of cell 
homogenate protein as the enzyme source, 2.8 
mM NaCl, 100 mM KCl, 10 mM MgCl2, 112 mM 
glucose, HEPES buffer pH 7.5, 1,5 μCi of [32P] 
ATP (specific activity 3000 Ci/mmol; 
PerkinElmer) and the indicated amounts of c-Fos 
or NA. Conditions of linearity with time and 
protein concentration were determined for the 
enzyme with 1 ng of recombinant proteins per μg 
of protein cell homogenate, suspended in 3 μL of 
elution buffer or an equal volume of elution buffer 
for control reactions. For the competition 
conditions, the ratios between c-Fos and NA were 
calculated according to the number of molecules 
of each protein. Reactions were stopped by the 
addition of trichloroacetic acid (TCA) and 
phosphotungstic acid (PTA; 5–0.5% w/v, 
respectively). Incubates were centrifuged and the 
pellet was washed three more times with TCA-
PTA 5:0,5 %w/v. After a final washing step with 
water, the pellet was suspended in 1.5 mL of 
chloroform:metanol 2:1. In this phase 
partitioning, lipids remain in the organic phase. 
Phospholipid labelling was quantified in the 
organic phase by scintillation counting 
(30,74,75). A more detailed version of the 
protocol has been published (76). 
Enzyme Activity Determinations. Total CDS 
activity was assayed as described by Lykidis et al. 
1997 (37). All reactions were performed in 80 μL 
of final volume containing 100 μg of cell 
homogenate protein as the enzyme source, 0.69 
μM [3H]-CTP (Perkin-Elmer, Waltham, 
Massachusetts, United States) and 2 mM 
phosphatidic acid (Avanti Polar Lipids, Alabaster, 
Alabama, United States). Conditions of linearity 
with time and protein concentration were 
determined for the enzyme with 0.5 ng of 
recombinant c-Fos per μg of protein cell 
homogenate, suspended in 3 μL of elution buffer 
or an equal volume of elution buffer for control 
reactions (29,38). The reaction was started by the 
addition of 10 mM MgCl2 and assays were 
incubated at 37°C for 1 hour. Reactions were 
stopped by the addition of 180 μL of 
chloroform/methanol/HCl (1:2:0.02% v/v). After 
addition of 60 μL of chloroform and 60 μL of KCl 
2M, phases were separated by centrifugation. The 
amount of [3H]-CDP-diacylglycerol synthesized 
was determined by liquid scintillation counting in 
the organic phase. 
Immunofluorescence (IF) and microscopy. Cells 
grown on round, acid-washed coverslips were 
rinsed twice with ice-cold 10 mM PBS and fixed 
in para-formaldehyde 4% (w/v) (Sigma Aldrich, 
St. Louis, Missouri, United States), sucrose 4% 
(w/v) (Sigma Aldrich, St. Louis, Missouri, United 
States) in 10 mM PBS at 37°C for 10 minutes. 
Cells were then permeabilized with Triton X-100 
0.1% (v/v) (Sigma Aldrich, St. Louis, Missouri, 
United States) in 10 mM PBS during 10 minutes 
and blocked with Horse Serum 2% (v/v) and 
Bovine Serum Albumin 3% (w/v) in 10 mM PBS 
for 2 hours at RT in a humid chamber. Samples 
were incubated overnight at 4°C in blocking 
buffer containing the desired antibody, washed 
twice with 10 mM PBS and incubated with 
secondary antibodies for 2 hours at RT, washed 
and mounted with FluorSave (Millipore, 
Burlington, Massachusetts, United States). When 
indicated, DAPI (4,6-diamino-2-phenylindole, 
dihydrochloride, Thermo Fisher Scientific, 
Waltham, Massachusetts, United States) was used 
to visualize nuclear structures.  
Antibodies. The following primary antibodies 
were used: rabbit polyclonal anti-c-Fos antibody 
(Santa Cruz Biotechnology, Dallas, Texas, United 
States) diluted 1:200 for IF; rabbit polyclonal anti-
c-Fos antibody (Sigma Aldrich, St. Louis, 
Missouri, United States) diluted 1:2000 for WB; 
mouse monoclonal anti-α-Tubulin antibody 
(Sigma Aldrich, St. Louis, Missouri, United 
States) diluted 1:3000 for WB; mouse monoclonal 
anti-βIII-Tubulin antibody (Sigma Aldrich, St. 
Louis, Missouri, United States) diluted 1:1500 for 
IF; goat polyclonal anti-calnexin antibody (ER 
marker, Abcam, Cambridge, United Kingdom) 
diluted 1:500 for IF; rabbit polyclonal anti-
CCTβ2 antibody (Sigma Aldrich, St. Louis, 
Missouri, United States) diluted 1:500 for IF. The 
following secondary antibodies were used: IRDye 
800CW goat anti-mouse antibody and IRDye 800 
goat anti-rabbit antibody (LI-COR, Lincoln, 
Nebraska, United States) diluted 1:25000 for WB; 
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Alexa 488, Alexa 546 and Alexa 633 (Thermo 
Fisher Scientific, Waltham, Massachusetts, 
United States) diluted 1:1000 for IF. 
FRET analysis. Cells grown on round, acid-
washed coverslips in 24 multiwell plates were 
transfected with c-Fos-mTurquoise2-N1, CDS-
pSYFP2, CCTβ2-pSYFP2, pSYFP2-
mTurquoise2 or the empty vectors using 
Lipofectamine 2000 according to the 
manufacturer´s protocol. After 24 hours of 
transfection, cells were rinsed twice with ice-cold 
10 mM PBS and fixed in para-formaldehyde 4% 
(w/v) (Sigma Aldrich, St. Louis, Missouri, United 
States), sucrose 4% (w/v) (Sigma Aldrich, St. 
Louis, Missouri, United States) in 10 mM PBS at 
37°C for 10 minutes. Cells were then washed 
three times with PBS and rinsed with Milli-Q 
water. Coverslips were mounted with FluorSave 
(Millipore, Burlington, Massachusetts, United 
States) and cells visualized using an Olympus 
FV1000 laser scanning confocal microscope with 
Olympus Fluoview Software (Olympus, 
Shinjuku, Tokyo, Japan). For FRET 
determinations, the sensitized emission 
measurement approach was used (36). The 
mTurquoise (donor) and SYFP (acceptor) 
chimeric proteins were excited with an argon laser 
at 458 and 515 nm, respectively. The emission 
channel was 470–500 nm for the donor and 530–
560 nm for the acceptor. Background values were 
determined independently for each channel from 
a coverslip with non-transfected cells and then 
subtracted using ImageJ software. Donor spectral 
bleedthrough and acceptor cross excitation were 
calculated and corrected from single transfected 
cells. Mean FRET efficiency values (%E) within 
a cell were obtained on a pixel-by-pixel basis (31). 
The resulting image was then pseudo-colored to 
better illustrate the distribution of the calculated 
efficiencies in the cell. 
In utero electroporation. In utero electroporation 
was performed as previously described (77) with 
minor modifications. Briefly, pregnant C57BL/6J 
mice at E15 days were anaesthetized with 
ketamine/xylazine (Laboratorios Richmond, 
Ciudad Autónoma de Buenos Aires, Argentina). 
Needles for injections were pulled from P-97 
Flaming/Brownglass capillaries (World Precision 
Instruments, Sarasota, Florida, United States). 
shRNA solutions were mixed with Tripan blue 
1% (v/v) at a DNA concentration of 0.5–
1.5 µg/µL for each construct and injected. Five 
pulses of 40V (50 ms ON, 950 OFF) were applied 
using 5 mm electrodes and a specially 
manufactured electroporator (LIADE National 
University of Córdoba, Córdoba, Córdoba, 
Argentina). The embryos were placed back into 
the abdominal cavity which was then sutured. 
After 3 days post intervention, the mother was 
sacrificed by cortical dislocation, the embryos 
removed and the brains of the electroporated ones 
extracted and fixed with 4% (w/v) para-
formaldehyde (Sigma Aldrich, St. Louis, 
Missouri, United States) for 24 hours. Then, they 
were cryo-protected by immersion in Sucrose 
30% (w/v) (Sigma Aldrich, St. Louis, Missouri, 
United States) and finally embedded in medium 
for frozen tissue specimens to ensure optimal 
cutting temperature (O.C.T) and freezed in 
Nitrogen. After 3 days at -80°C, coronal 
cryosections of 20 µm were obtained and 
processed for immunofluorescence.  
Microscope image acquisition. Imaging was 
performed on an Olympus FV1000 laser scanning 
confocal microscope Using Olympus Fluoview 
Software (Olympus, Shinjuku, Tokyo, Japan) 
using a 60× (1.4 NA) oil objective or a 10× (0.40 
NA) air objective. Images were analyzed with 
ImageJ Software.  
Experimental design and statistical analysis. All 
the statistical analysis were performed using 
GraphPad Prism software. Statistical significance 
was defined by a p value < 0.05. The statistical 
test performed and the number of replicates for 
each experiment are indicated in the 
correspondent figure legend. 
Animal care. All the procedures were performed 
according to the “Guide for the care and use of 
laboratory animals” (8th Edition, USA) and the 
approved protocols of the Institutional Board for 
Animal Welfare (CICUAL, Facultad de Ciencias 
Químicas, Universidad Nacional de Córdoba). 
Data availability.  All data are contained within 
the manuscript. 
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c-Fos is expressed in primary rat hippocampal neuronal cultures. (A) Rat primary 
hippocampal neurons were fixed at different times of culture and immuno-stained with an 
anti c-Fos antibody (red). h: hours. Scale bar: 20 µm. (B) Western Blot of hippocampal cell 
lysates harvested at different times of culture. Membranes were immuno-stained with an anti 
c-Fos antibody (upper panel) and an anti-Tubulin antibody (lower panel) as a loading control 
and secondary antibodies suitable for near infrared fluorescence. The obtained images were 




















Blocking the activity or the expression of c-Fos impairs neuronal differentiation. (A) Cells 
were profected with anti c-Fos (c-Fos Ab) or with a non-related anti mouse IgG antibody as 
a control (Control Ab) 2 hours after seeding using BioPorter and then were fixed after 48 
hours of culture. The different morphological aspects were quantified from microscopy 
images, using ImageJ software, and are shown as the mean ± SD in each case. Student’s t 
test statistical analysis was performed using GraphPad Software. ***p< 0.001; n.s.: non-
significant; in each experiment, n=40 cells from each condition were examined. Results of 
one of three independent experiments performed are shown.  (B) Cells were infected at the 
initiation of the culture with lentiviral particles designed to express an anti c-Fos shRNA or 
a shRNA with a scrambled sequence of c-Fos as a control. After 48 hours of culture cells 
were fixed and immune-stained with an anti c-Fos antibody (red, first column) and an anti 
βIII-Tubulin antibody (green, second column). The third column shows the merge between 
both labels.  Scale bar: 20 µm. (C) Morphological quantification of neuronal differentiation 
stages in both c-Fos and scrambled infected cells was performed using ImageJ software. The 
graph shows the mean number of cells ± SD in each case. Student’s t test statistical analysis 
was performed using GraphPad Software. *p< 0.05; ***p< 0.001; n.s.: non-significant; 
n=198 cells for scrambled infected cells, n=254 cells for c-Fos infected cells. Results of one 
of three independent experiments performed are shown.  

















c-Fos co-localizes with ER markers. Immunocytochemistry of c-Fos (red), the ER marker 
Calnexin (green) and βIII-Tubulin (cyan) of rat hippocampal neurons at 48 hours of culture. 
The fourth panel shows the merged images between the three labels. A Pearson’s R value of 
0,81 was calculated for co-localization of both labels (Coloc2, ImageJ). An inset is shown 
with a co-localization analysis between c-Fos and the ER, where the co-localizing pixels are 
colored in white (Colocalization Finder, ImageJ). Scale bar: 20 µm. The results of one of 
three independent experiments are shown.  

















c-Fos activates and physically interacts with CDS. (A) Upper row, neurons were co-
transfected at 24 hours of culture to express c-Fos-CFP (first panel) and CDS-YFP (second 
panel) and examined by confocal microscopy at 48 hours. FRET images were obtained by 
the sensitized emission method and pseudo-colored using ImageJ software (third panel). The 
lower row shows a negative control with cells co-transfected with the CFP empty vector and 
CDS-YFP. Scale goes from no FRET (black) to maximum FRET (yellow). Scale bar: 30 µm. 
(B) The graphic shows the quantification of the mean efficiencies ± SD for the donor/acceptor 
pairs shown in the images, with one-way ANOVA analysis and Tukey’s post-test.  
***p<0.001; n=25 cells for each condition. The results of one of three independent 
experiments are shown. (C) Evaluation of CDS activity through the measurement of the 
incorporation of [3H]-CTP into CDP-DAG in neurons homogenates in the presence of c-Fos 
(+ c-Fos). Elution buffer was used as a control (- c-Fos). Results are the mean of three 
independent experiments performed in triplicate. The results are expressed as the mean ± SD, 
with t-Student analysis.  *p<0.05.  
















NA deletion mutant of c-Fos impairs differentiation in neuronal cultures and abrogates c-
Fos-dependent lipid synthesis activation. (A) Neuronal cultures were transfected at seeding 
with NA-YFP (pseudo-colored red, lower row), or NB-YFP (pseudo-colored red, middle 
row) or the empty vector as a control (pseudo-colored red, upper row) and were fixed after 
48 hours of culture. Cells were subjected to immunofluorescence against βIII-tubulin (green, 
second column). Scale bar: 20 µm. (B) Morphological quantification of neuronal 
differentiation stages in both NA-YFP and NB-YFP transfected cells at different fixation 
times. The results of one of three independent experiments are shown. Normality 
Kolmogorov-Smirnov test was performed, where the deviation from the distribution respect 
to the NB transfected cells was evaluated. *p<0.05; ***p<0.001; n.s.: non-significant; n=15 
from each condition were examined. (C) Evaluation of 32P-phospholipid labelling capacity 
of neuron homogenates in the presence of c-Fos (+c-Fos), NA (+NA) or both (+c-Fos +NA 
1:1 and +c-Fos +NA 1:3). Elution buffer was used as a control (Control). Results are the 
mean of three independent experiments performed in triplicate. The results are expressed as 
the mean ± SD, with one-way ANOVA analysis.  ***p<0.001 respect to control condition.  
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Figure 6  
 
 
Expression of c-Fos is involved in cortical development. (A) Embryo brains were 
electroporated with a specifically designed shRNA to block c-Fos expression (sh c-Fos) 
(right) or a control scrambled shRNA (left) at E15 and analyzed at E19. IUE: in utero 
electroporation; VZ: ventricular zone; SVZ: subventricular zone; IZ; intermedial zone; CP: 
cortical plate; MZ: marginal zone. Scale bar = 100 μm. (B) Quantification of the distribution 
of dsRed-positive cells in the CP, IZ and VZ/SVZ. The mean ± SD of the quantification of 
at least 20 coronal cryo-sections from three independent experiments performed 
independently is shown, with two way Anova statistical analysis with Bonferroni post-test. 
*** p < 0.001; n.s.: non-significant. (C) Embryo brains were electroporated with a vector 
designed to express the NA domain of c-Fos fused to CFP or the empty vector as a control at 
E15 and analyzed at E19. (D) Quantification of the distribution of dsRed-positive cells in the 
CP, IZ and VZ/SVZ. The mean ± SD of the quantification of at least 20 coronal cryo-sections 
from three independent experiments performed independently is shown, with two way Anova 
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